Skip to main content
. 2021 Dec 6;8(1):e001071. doi: 10.1136/bmjresp-2021-001071

Table 1.

Calculated total greenhouse gas emissions from inhaled products in 2019 for each of the five reference markets. Values are given to two significant figures

UK Italy France Germany Spain
Market share %
 pMDIs 69.6 37.3 52.2 42.6 44.9
 DPI/SMIs 30.4 62.7 47.8 57.4 55.1
Whole market
 CO2e emissions, kilo tons 1 300 190 520 450 330
 From pMDIs, kilo tons (%) 1 200 (98.4) 170 (93.7) 500 (96.6) 430 (94.7) 320 (95.8)
 From DPI/SMIs, kilo tons (%) 20 (1.6) 12 (6.3) 18 (3.4) 24 (5.3) 14 (4.2)
Of which SABA
 CO2e emissions, kilo tons 870 98 370 300 220
 From pMDIs, kilo tons (%) 870 (99.9) 97 (99.2) 370 (99.98) 300 (99.9) 220 (99.7)
 From DPI/SMIs, kilo tons (%) 1.3 (0.1) 0.76 (0.8) 0.058 (0.02) 190 (0.1) 580 (0.3)
Whole market without SABA
 CO2e emissions, kilo tons 380 88 150 160 110
 From pMDIs, kilo tons (%) 370 (95.2) 77 (87.5) 130 (87.9) 130 (84.7) 95 (87.8)
 From DPI/SMIs, kilo tons (%) 18 (4.8) 11 (12.5) 18 (12.1) 24 (15.3) 13 (12.2)

Market share is based on the number of packs sold in 2019 in the five reference markets.

CO2e, carbon dioxide equivalent; DPI, dry-powder inhaler; pMDI, pressurised metered-dose inhaler; SABA, short-acting β2-agonist; SMI, soft mist inhaler.